Adverse events20

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 20

Type	Event	Organ system	Group	Affected	At risk
other	Application site dryness	General disorders	Olumacostat Glasaretil Gel, 5.0%	13	485
other	Application site dryness	General disorders	Olumacostat Glasaretil Gel, Vehicle	2	258
other	Application site erythema	General disorders	Olumacostat Glasaretil Gel, 5.0%	13	485
other	Application site erythema	General disorders	Olumacostat Glasaretil Gel, Vehicle	3	258
other	Application site pain	General disorders	Olumacostat Glasaretil Gel, 5.0%	19	485
other	Application site pain	General disorders	Olumacostat Glasaretil Gel, Vehicle	11	258
other	Application site pruritus	General disorders	Olumacostat Glasaretil Gel, 5.0%	13	485
other	Application site pruritus	General disorders	Olumacostat Glasaretil Gel, Vehicle	4	258
other	Nasopharyngitis	Infections and infestations	Olumacostat Glasaretil Gel, 5.0%	15	485
other	Nasopharyngitis	Infections and infestations	Olumacostat Glasaretil Gel, Vehicle	5	258
other	Upper respiratory tract infection	Infections and infestations	Olumacostat Glasaretil Gel, 5.0%	16	485
other	Upper respiratory tract infection	Infections and infestations	Olumacostat Glasaretil Gel, Vehicle	8	258
serious	Constipation	Gastrointestinal disorders	Olumacostat Glasaretil Gel, 5.0%	0	485
serious	Constipation	Gastrointestinal disorders	Olumacostat Glasaretil Gel, Vehicle	1	258
serious	Appendicitis	Infections and infestations	Olumacostat Glasaretil Gel, 5.0%	0	485
serious	Appendicitis	Infections and infestations	Olumacostat Glasaretil Gel, Vehicle	1	258
serious	Epilepsy	Nervous system disorders	Olumacostat Glasaretil Gel, 5.0%	1	485
serious	Epilepsy	Nervous system disorders	Olumacostat Glasaretil Gel, Vehicle	0	258
serious	Bipolar disorder	Psychiatric disorders	Olumacostat Glasaretil Gel, 5.0%	0	485
serious	Bipolar disorder	Psychiatric disorders	Olumacostat Glasaretil Gel, Vehicle	1	258

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03028363/events

API reference For AI assistants